|
Code
|
76533
|
|
MA number
|
15/0316/09-S
|
|
Product Form:
|
plv ifo 1x2g/0,25g (50 ml liek.inj.skl.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Decentralised
|
|
MAH, country:
|
Fresenius Kabi s.r.o., Czechia
|
|
Therapeutic Class:
|
15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J01 |
ANTIBACTERIALS FOR SYSTEMIC USE |
| J01C |
BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| J01CR |
Combinations of penicillins, incl. beta-lactamase |
| J01CR05 |
Piperacillin and enzyme inhibitor |
|
|
Shelf life:
|
36 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intravenous use
|
PIL_Piperacillin_Tazobactam Kabi 2g_0,25g_05.2022.pdf
